International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Remote Patient Monitoring Market Research Report 2023-2028:
According to the latest report by IMARC Group, titled " RemotePatientMonitoringMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandF orecast2023-2028
," the global remote patient monitoring market size reached US$ 1.3 Billion in 2022.
Remote patient monitoring (RPM) is a healthcare delivery method that uses the latest advances in information technology to gather patient data outside of traditional healthcare settings. It collects a wide range of health data from the point of care, such as weight, blood sugar and oxygen levels, heart rate, and electrocardiograms, which is electronically transferred to health care providers for assessment.
These programs allow older and disabled individuals to live at home for longer and avoid moving to nursing facilities. This, in turn, aids in reducing the patientcare cost, number of hospitalizations, readmissions and length of stays in hospitals.
Request for a PDF sample of this report:
https://www.imarcgroup.com/remote-patient-monitorning-market/requestsample
The highly infectious nature of the coronavirus disease (COVID-19) has prompted healthcare providers to utilize RPM services for monitoring patients and improving the quality of care. RPM technology consists of medical devices deployed in the home that transmit vital signs through a data hub, console or set-top box. This helps healthcare providers to free up resources for treating critical and existing patients by providing more timely and efficient care. Besides this, the rapid advancements in wireless technologies and healthcare infrastructure, and the increasing penetration of smartphones has led to a shift from clinic- to patient-centric healthcare models, such as RPM.
As a result, the leading players are introducing next-generation chronic disease RPM systems based on mobile phone platforms that would allow automatic wireless transfer of measurements from medical devices, like glucometers, blood pressure monitors and weighing scales.
Looking forward, IMARC Group expects the market is anticipated to exhibit a CAGR of 15.4% during theforecastperiod(2023-2028).
View Report TOC, Figures and Tables: https://www.imarcgroup.com/remote-patient-monitorning-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Device Type:
• Blood Pressure Monitor
• Glucose Monitor
• Heart Rate Monitor
• Pulse Oximeters
• Respiratory Monitor
• Others
Breakup by Application:
• Cancer Treatment
• Cardiovascular Diseases Treatment and Monitoring
• Diabetes Treatment
• Sleep Disorder Treatment
• Weight Management and Fitness Monitoring
• Others
Breakup by End-Use:
• Hospitals and Clinics
• Homecare Settings
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• Abbott Laboratories
• AMD Global Telemedicine Inc
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Dexcom, Inc
• GE Healthcare Inc. (Danaher Corporation)
• Honeywell International Inc
• Koninklijke Philips N.V
• Medtronic Inc
• Nihon Kohden Corporation
• OSI Systems Inc
• Roche Holding AG
• etc
1. Whatwasthesizeoftheglobalremotepatientmonitoringmarketin2022?
2. Whatistheexpectedgrowthrateoftheglobalremotepatientmonitoringmarketduring20232028?
3. Whatarethekeyfactorsdrivingtheglobalremotepatientmonitoringmarket?
4. WhathasbeentheimpactofCOVID-19ontheglobalremotepatientmonitoringmarket?
5. Whatisthebreakupoftheglobalremotepatientmonitoringmarketbasedonthedevicetype?
6. Whatisthebreakupoftheglobalremotepatientmonitoringmarketbasedontheapplication?
7. Whatisthebreakupoftheglobalremotepatientmonitoringmarketbasedontheend-use?
8. Whatarethekeyregionsintheglobalremotepatientmonitoringmarket?
9. Whoarethekeyplayers/companiesintheglobalremotepatientmonitoringmarket?
Clickheretovisitthecompletetableofcontentwithlistoffiguresandtables: https://www.imarcgroup.com/remote-patient-monitorning-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
